EQS-News: Rapid Nutrition Secures Distribution Deal in Sri Lanka

Rapid Nutrition Secures Distribution Deal in Sri Lanka
("Rapid Nutrition" or "the Company")

London July 11, 2018: The board is pleased to announce Rapid Nutrition has continued to expand in the rapidly growing Asia market securing a distribution agreement with Schering Life Sciences to market and distribute the Companies flagship brand SystemLS.

The agreement is expected to generate an additional $1,090,437 in revenue for the company in the first 12mths. Product registration is currently in process and expected to be completed this quarter with the first order to scheduled for later this year.

Simon St. Ledger, Chairman of Rapid Nutrition said:
"Rapid is making excellent progress internationally by partnering with well established retailers and distributors such as GNC; and Schering Life Science is another which we are delighted to be partnering with and who have deep roots and relationships in the emerging Sri Lankan market."

Further enquires:

Email: info@rnplc.com
Phone: +44 20 3239 2561
Website: rnplc.com

About Rapid
Rapid is a natural healthcare company focused on the research and development, manufacturing and distribution of weight-loss and diet management products, sports nutrition products, vitamins and dietary supplements and a range of life science products. The Company has registered products in and or exported its products to Australia, Asia, Europe, Middle East, Africa and the US.

This communication expressly or implicitly contains certain forward-looking statements concerning Rapid Nutrition PLC and its business. Such statements involve certain known and unknown risks, uncertainties and other factors, which could cause the actual results, financial condition, performance or achievements of the Rapid Nutrition group to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Rapid Nutrition PLC is providing this communication as of this date and does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise.